Screener
HEAL vs IDNA
Global X HealthTech ETF vs iShares Genomics Immunology and Healthcare ETF
Key differences
- IDNA is significantly larger than HEAL — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, IDNA has delivered higher annualized returns.
Side-by-side comparison
| HEAL | IDNA | |
|---|---|---|
| Annual cost (TER) | 0.50% | 0.47% |
| Fund size (AUM) | $25M | $160M |
| Since | 2020 | 2019 |
| Dividend yield | 0.38% | 1.05% |
| Asset class | equity | equity |
| Region | north america | — |
| Strategy | index tracking | index tracking |
| CAGR 1Y | -20.2% | +49.2% |
| CAGR 3Y | -10.3% | +8.0% |
| CAGR 5Y | -14.0% | -7.5% |
| Sharpe 3Y | -0.46 | 0.29 |
| Volatility 1Y | 21.71% | 24.43% |
| Max drawdown | -65.76% | -68.26% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to HEAL and IDNA
Explore further